Genetic screening technique could enhance CAR-T therapies for multiple myeloma and other cancers
Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that can improve the efficacy of chimeric antigen receptor (CAR)-T cell treatment—an immunotherapy that ...
Sep 24, 2025
0
35








